Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | MoonLake Immunotherapeutics | Open-market sale | −1,932,354 | $16.79 | $32,444,224 |
| Mar 31, 2026 | MoonLake Immunotherapeutics | Open-market sale | −1,569,116 | $16.79 | $26,345,458 |
| Mar 31, 2026 | MoonLake Immunotherapeutics | Open-market sale | −248,530 | $16.79 | $4,172,819 |
Questions about Mark N. Lampert
What boards is Mark N. Lampert on?
Mark N. Lampert sits on the boards of Immunic Inc., Kymera Therapeutics Inc., MoonLake Immunotherapeutics and Olema Pharmaceuticals Inc.
How long has Mark N. Lampert served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.